Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
Saved in:
| Title: | Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease. |
|---|---|
| Authors: | Chahine, L. M., Dos Santos, C., Fullard, M., Scordia, C., Weintraub, D., Erus, G., Rosenthal, L., Davatzikos, C., McMillan, C. T. |
| Source: | European Journal of Neurology. Feb2019, Vol. 26 Issue 2, p246-246. 1p. 1 Black and White Photograph, 4 Charts. |
| Subjects: | Parkinson's disease, Mild cognitive impairment, Alzheimer's disease, Brain diseases, Neurodegeneration |
| Abstract: | Background and purpose: Dementia in Parkinson's disease (PD) is common and disabling. Identification of modifiable risk factors for it is essential. Vascular risk factors (VRFs) may be associated with cognitive decline in early PD. Biomarkers that serve as surrogates of the long‐term effect of VRFs on PD are needed. To that end, we aimed to quantitate white matter hyperintensities (WMH) in early PD, measure associations with VRFs and examine relationships between WMH and longitudinal cognition. Methods: Participants in the Parkinson's Progression Markers Initiative study (141 patients with PD, 63 healthy controls) with adequate baseline structural brain magnetic resonance imaging data were included. Hypertension and diabetes history, and body mass index were combined to create a vascular risk score. WMH were quantitated via automated methods. Cognition was assessed annually with a comprehensive test battery. Results: In the PD group, vascular risk score was associated with WMH for total brain (β = 0.210; P = 0.021), total white matter (β = 0.214; P = 0.013), frontal (β = 0.220; P = 0.002) and temporal (β = 0.212; P = 0.002) regions. Annual rate of change in global cognition was greater in those with higher vascular risk score (β = −0.040; P = 0.007) and greater WMH (β = −0.029; P = 0.049). Higher temporal WMH burden was associated with great decline over time in verbal memory (β = −0.034; P = 0.031). Conclusions: In early PD, modifiable VRFs are associated with WMH on brain magnetic resonance imaging. Temporal WMH burden predicts decline in verbal memory. WMH may serve as a surrogate marker for the effect of VRFs on cognitive abilities in PD. [ABSTRACT FROM AUTHOR] |
| Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 134091373 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Chahine%2C+L%2E+M%2E%22">Chahine, L. M.</searchLink><br /><searchLink fieldCode="AR" term="%22Dos+Santos%2C+C%2E%22">Dos Santos, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Fullard%2C+M%2E%22">Fullard, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Scordia%2C+C%2E%22">Scordia, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Weintraub%2C+D%2E%22">Weintraub, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Erus%2C+G%2E%22">Erus, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Rosenthal%2C+L%2E%22">Rosenthal, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Davatzikos%2C+C%2E%22">Davatzikos, C.</searchLink><br /><searchLink fieldCode="AR" term="%22McMillan%2C+C%2E+T%2E%22">McMillan, C. T.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Neurology%22">European Journal of Neurology</searchLink>. Feb2019, Vol. 26 Issue 2, p246-246. 1p. 1 Black and White Photograph, 4 Charts. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Parkinson's+disease%22">Parkinson's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Mild+cognitive+impairment%22">Mild cognitive impairment</searchLink><br /><searchLink fieldCode="DE" term="%22Alzheimer's+disease%22">Alzheimer's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Brain+diseases%22">Brain diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Neurodegeneration%22">Neurodegeneration</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background and purpose: Dementia in Parkinson's disease (PD) is common and disabling. Identification of modifiable risk factors for it is essential. Vascular risk factors (VRFs) may be associated with cognitive decline in early PD. Biomarkers that serve as surrogates of the long‐term effect of VRFs on PD are needed. To that end, we aimed to quantitate white matter hyperintensities (WMH) in early PD, measure associations with VRFs and examine relationships between WMH and longitudinal cognition. Methods: Participants in the Parkinson's Progression Markers Initiative study (141 patients with PD, 63 healthy controls) with adequate baseline structural brain magnetic resonance imaging data were included. Hypertension and diabetes history, and body mass index were combined to create a vascular risk score. WMH were quantitated via automated methods. Cognition was assessed annually with a comprehensive test battery. Results: In the PD group, vascular risk score was associated with WMH for total brain (β = 0.210; P = 0.021), total white matter (β = 0.214; P = 0.013), frontal (β = 0.220; P = 0.002) and temporal (β = 0.212; P = 0.002) regions. Annual rate of change in global cognition was greater in those with higher vascular risk score (β = −0.040; P = 0.007) and greater WMH (β = −0.029; P = 0.049). Higher temporal WMH burden was associated with great decline over time in verbal memory (β = −0.034; P = 0.031). Conclusions: In early PD, modifiable VRFs are associated with WMH on brain magnetic resonance imaging. Temporal WMH burden predicts decline in verbal memory. WMH may serve as a surrogate marker for the effect of VRFs on cognitive abilities in PD. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=134091373 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/ene.13797 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: 246 Subjects: – SubjectFull: Parkinson's disease Type: general – SubjectFull: Mild cognitive impairment Type: general – SubjectFull: Alzheimer's disease Type: general – SubjectFull: Brain diseases Type: general – SubjectFull: Neurodegeneration Type: general Titles: – TitleFull: Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chahine, L. M. – PersonEntity: Name: NameFull: Dos Santos, C. – PersonEntity: Name: NameFull: Fullard, M. – PersonEntity: Name: NameFull: Scordia, C. – PersonEntity: Name: NameFull: Weintraub, D. – PersonEntity: Name: NameFull: Erus, G. – PersonEntity: Name: NameFull: Rosenthal, L. – PersonEntity: Name: NameFull: Davatzikos, C. – PersonEntity: Name: NameFull: McMillan, C. T. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 13515101 Numbering: – Type: volume Value: 26 – Type: issue Value: 2 Titles: – TitleFull: European Journal of Neurology Type: main |
| ResultId | 1 |